Recruiting Von Willebrand Disease Studies in New Haven
About Von Willebrand Disease Clinical Trials in New Haven
Von Willebrand disease is the most common inherited bleeding disorder, caused by deficiency or dysfunction of von Willebrand factor, a protein needed for blood clotting. Most cases are mild with excessive bleeding during surgery or dental work. Treatment includes desmopressin and von Willebrand factor concentrates.
There are currently 2 von willebrand disease clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 170 participants. Research is being sponsored by University of Washington, Vega Therapeutics, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Von Willebrand Disease Clinical Trials in New Haven — FAQ
Are there von willebrand disease clinical trials in New Haven?
Yes, there are 2 von willebrand disease clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What von willebrand disease treatments are being tested?
The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for von willebrand disease.
Data updated October 15, 2026 from ClinicalTrials.gov